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Actinobacillus pkuropneumoniae produces several hemolysins/cytotoxins that may be important in the
pathogenesis of acute lesions. Little is known, however, about the role of these virulence factors in chronic
disease or the carrier state. We investigated the effects of live bacterial infection and transthoracic injection of
a sterile culture supernatant on primary lymphoid organs and lymphocyte populations. Transthoracic
inoculation of mice or intranasal inoculation of pigs with virulent A. pleuropneumoniae serotypes 1 and 7
induced thymic cortical lymphoid necrosis. These lesions were reproduced in mice by transthoracic injection
of a concentrated sterile culture supernatant. The cytotoxic effect of this culture supernatant was also
demonstrated in vitro by using a tetrazolium dye reduction assay. Both porcine and murine thymic
lymphocytes as well as splenic T lymphocytes were susceptible to the toxin. Porcine convalescent serum, but not
preimmune serum, prevented thymic lesions and neutralized the in vitro cytotoxic effect of the culture
supernatant on murine thymic lymphocytes. Thymic lesions also were reproduced in mice by using purified
lipopolysaccharide (LPS) from Escherichia coli O111:B4; however, LPS had no in vitro cytotoxic effect on
either porcine or murine thymic lymphocytes. These results suggest that secreted A. pleuropneumoniae toxin(s)
is capable of affecting host T-lymphocyte populations and may affect host immune function.
Actinobacillus pleuropneumoniae is the etiologic agent of
porcine pleuropneumonia, a disease which costs pork pro-
ducers millions of dollars each year from death of animals,
reduced feed efficiency, prophylactic medication, and vac-
cination costs (13). The disease is characterized by lesions
which include severe necrohemorrhagic pneumonia, pleuri-
tis, and suppurative lymphadenitis. Animals which survive
acute infections often become chronic carriers, having poor
growth characteristics and increased susceptibility to sec-
ondary infections (13, 15). The organism possesses many
virulence factors (capsule, lipopolysaccharide [LPS], hemo-
lysins, cytotoxins, and proteases) thought to be important in
the pathogenesis of acute disease (1, 5, 6, 9, 14). A recent
report has suggested that vaccination with preparations
containing secreted factors, such as hemolysin/cytotoxin,
provides enhanced protection from acute disease (4). Little
is known, however, about the role of these virulence factors
in the production of chronic disease and the carrier state.
Therefore, we investigated the effects of live bacterial infec-
tion or sterile culture supernatants from two A. pleuropneu-
moniae serotype 1 and 7 reference strains on the lymphoid
organs and lymphocyte populations of mice and pigs. If the
organism or its putative virulence factors could affect the
primary and secondary lymphoid organs as well as lympho-
cyte populations, then infection by the organism may inhibit
the immunologic response of animals and subsequently
contribute to chronic disease and the carrier state.
MATERIALS AND METHODS
Bacteria. A. pleuropneumoniae serotype 1 and 7 reference
strains were obtained from Brad Fenwick, College of Veter-
inary Medicine, Kansas State University, Manhattan. Bac-
teria were grown and maintained as described previously (4).
* Corresponding author.
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To prepare inocula, bacteria were grown overnight in a
shaker bath at 37°C in brain heart infusion broth (Difco
Laboratories, Detroit, Mich.) containing 0.01% (wt/vol)
NAD (Sigma Chemical Co., St. Louis, Mo.). The following
morning, 0.5 ml of the culture was added to 50 ml of fresh
medium, and the culture was reincubated for an additional 3
h. The bacteria were harvested by centrifugation at 10,000 x
g for 15 min and then resuspended in phosphate-buffered
saline (PBS; pH 7.4) to an optical density at 600 nm (OD6.)
of 0.05 to 0.075 (approximately 4 x 107 CFU/ml). Additional
dilutions of this suspension were made in PBS to prepare
suspensions for intranasal inoculation of pigs and transtho-
racic injection of mice.
Animals and inoculation methods. Pigs used in this study
were obtained from the University of Nebraska closed
specific-pathogen-free herd, which is periodically monitored
for the presence of respiratory pathogens and has had no
previous clinical history of pleuropneumonia. BALB/c mice
were obtained from a University of Nebraska breeding
colony. All animals were housed and maintained in isolation
facilities in accordance with our institutional animal care and
use committee guidelines.
Acute pleuropneumonia was induced in pigs by using
pressurized aerosolization through a nasal cannula as de-
scribed previously (4). The inoculum consisted of 2 x 106
CFU of serotype 1 or 4 x 106 CFU of serotype 7 organisms
suspended in 5 ml of PBS. Mice were injected transthorac-
ically with 0.1 ml of a PBS suspension containing 2 x 107
CFU of serotype 1 or 2 x 107 CFU of serotype 7 organisms
per ml. In certain murine experiments, the bacterial inocu-
lum was replaced with 0.1 ml of a 10-fold concentrate from a
sterile cytotoxic culture supernatant described below or 0.1
ml of PBS containing 1.0 mg of purified LPS per ml from
Escherichia coli O111:B4 (Difco). Mice injected with 0.1 ml
of 10-fold-concentrated uninoculated media served as a
negative control. All mice and pigs were killed by euthanasia
24 h after inoculation, and tissues were immediately re-
moved and fixed in 10% buffered formalin. Following fixa-
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FIG. 1. (A) Normal pig thymic cortex. Magnification, x25. (B) Thymic cortex from a pig 24 h postinfection with A. pleuropneumoniae
serotype 7 organisms. Arrows indicate areas of cortical lymphocyte necrosis and dropout. Magnification, x25. (C) Normal mouse thymus.
Medulla (a); cortex (b). Magnification, x25. (D) Thymic cortex from a mouse transthoracically injected with serotype 1 10-fold-concentrated
culture supernatant. Cortical lesion is characterized by severe diffuse lymphoid necrosis and dropout. (E) Thymic cortex from a mouse
inoculated with serotype 1 10-fold-concentrated culture supernatant preincubated in homologous porcine convalescent serum. Thymic cortex
was protected from lesion development.
tion, tissues were processed and stained with hematoxylin
and eosin by routine methods for histologic examination.
Toxin production. Cytotoxin was prepared from the sero-
type 1 and 7 A. pleuropneumoniae reference strains by a
modification of a method described previously (3). Briefly,
bacteria were grown to log phase in the brain heart infusion-
NAD medium described above and harvested by centrifuga-
tion (10,000 x g for 15 min). The bacterial pellet was
resuspended in twice the original volume of RPMI 1640
medium (GIBCO Laboratories, Grand Island, N.Y.) con-
taining 1.05 g of bovine serum albumin (BSA; Sigma) per
liter. The culture was incubated in a shaker bath at 37°C for
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FIG. 1-Continued.
an additional 1.5 h. Bacteria were then removed from the
culture by centrifugation as described above, and the culture
supernatant was filter sterilized, divided into aliquots, and
frozen at -20°C. For certain experiments, aliquots of the
culture supernatants were heated for 30 min at 56°C to
determine heat lability of the toxin or concentrated 10-fold in
an Amicon stir cell (Diaflo; Amicon Div., Danvers, Mass.),
using a 10-kDa retention membrane for use in Western blot
(immunoblot) analysis. Other aliquots of the supernatants
were concentrated in a stir cell, using a 100-kDa retention
membrane. This retentate was reconstituted to its original
volume with RPMI medium containing 0.25% BSA (RPMI-
BSA). The original unconcentrated supernatant, reconsti-
tuted retentate, and the supernatant filtrate were tested for
toxicity to thymocytes. A. pleuropneumoniae serotype 1
cytotoxic culture supernatant was biosynthetically labeled in
the following manner. Bacterial cultures were grown and
harvested as above. Bacteria were then resuspended in 10 ml
of RPMI medium without methionine (RPMI Select Amine
Kit; GIBCO) and incubated at 37°C for 30 min. Bacterial
cells were then reharvested and resuspended in 20 ml of
RPMI-BSA medium containing 500 ,uCi of 35S-methionine
(New England Nuclear, Boston, Mass.). The culture was
then incubated at 37°C for an additional 90 min, and the
VOL. 59, 1991
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FIG. 1--Continued.
culture supernatant was harvested and sterilized as de-
scribed above. Aliquots of the labeled supernatant were
tested for cytotoxic activity on thymocytes.
EFdotoxin determinations. Endotoxin present in the 10-
fold-concentrated culture supernatants was measured by the
Limulus amebocyte lysate assay (Whittaker M.A. Bioprod-
ucts, Walkersville, Md.) per the manufacturer's instructions.
SDS-PAGE, Western blot, and autoradiographic analyses.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) as described by Laemmli (11) and immunoblot
analysis procedures were performed as reported previously
(4). Briefly, 10-fold concentrates of the culture supernatants
were electrophoresed for approximately 2.5 h at a constant
voltage of 75 V. Gels were stained with Coomassie brilliant
blue dye for protein identification. The proteins in duplicate
gels were transferred to nitrocellulose of 0.2-,um pore size
(Bio-Rad Laboratories, Richmond, Calif.). Successful trans-
fer was determined by staining the nitrocellulose with 0.2%
Ponceau S dye (Sigma), and molecular weight standards
were marked with a felt-tip marker. The nitrocellulose was
blocked overnight at 4°C in 3% fish gelatin (Sigma) and
reaWte4 for 1.5 h with 1:50 dilutions of preimmune, conva-
lescent, or convalescent porcine sera adsorbed with homol-
osous organisms (described below). The nitrocellulose blots
were thcn washed and reacted with alkaline phosphatase-
co)unpted goat anti-porcine immunoglobulin G (Kirkegaard
and Perry Laboratories, Gaithersburg, Md.). Color was
deve4pped by reaction with nitroblue tetrazolium-5-bromo-
4-chloro-3-indolyl phosphate toluidinium substrate reagent
(Kirkegaard and Perry) in accord with the manufacturer's
instructions. Autoradiographs of the biosynthetically labeled
serotype 1 toxin preparation were prepared by mixing a
100-,ul aliquot with an equal volume of 2x protein sample
buffer without 2-mercaptoethanol. The sample was then
heated at 100°C for 5 min and run in a 7% acrylamide gel as
described above. Proteins in the gel were transferred to
nitrocellulose and stained with Ponceau S to confirm protein
transfer. The nitrocellulose blot was then allowed to expose
Kodak X-Omat film (Sigma) for 7 days at -80°C prior to
development.
Convalescent sera. Convalescent sera were produced by
intranasal inoculation of one pig for each reference serotype
as reported previously (4). Blood was collected before
inoculation and at weekly intervals following infection. Sera
were harvested and stored in small aliquots at -20°C. Sera
from the blood collected from each animal on days 28, 35,
and 42 postinoculation were pooled for use in Western blot
analysis and passive protection experiments. A portion of
each respective pooled convalescent serum sample was
repeatedly adsorbed by incubation with approximately 1010
CFU of the homologous serotype 1 or 7 organisms per ml of
convalescent serum at 37°C for 10 min followed by centrif-
ugation at 15,000 x g for 20 min to remove bacteria from the
serum. Sera were heat inactivated (60°C for 40 min) prior to
use in passive protection experiments.
Passive protection experiments. Passive protection experi-
ments were performed with 5- to 8-week-old BALB/c mice
(five animals per inoculation group). A 100-,ul aliquot of
10-fold-concentrated sterile culture supernatant was mixed
with an equal volume of porcine convalescent serum (1:4
dilution in PBS) specific for the homologous bacterial sero-
type. The mixture (200-plI total volume) was incubated at
37°C for 10 min and then transthoracically injected into mice.
Mice inoculated with an identical aliquot of the supernatant
mixed with 1:4-diluted homologous preimmune serum
served as a positive control for evaluation of thymic lesions.
Mice inoculated with 200 p.1 of diluted convalescent serum
served as a negative control. All mice were killed by
euthanasia 24 h after inoculation, and tissues were collected
and processed as described above.
T-cell enrichment. Both porcine and murine splenic T
lymphocytes used in the in vitro cytotoxicity assays were
prepared by a method described previously (8). Splenic
lymphocytes were purified over Ficoll-Paque (Pharmacia,
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Piscataway, N.J.), following the manufacturer's instruc-
tions. After cells were washed with sterile PBS, they were
harvested and resuspended in RPMI-BSA medium at a cell
concentration of 5 x 107 per ml. A total of 108 cells were then
added to a syringe containing sterile nylon wool. The column
was incubated at 37°C for 1 h. Nonadherent cells were
harvested and resuspended in RPMI-BSA medium at a cell
concentration of 107 per ml for use in cytotoxicity assays.
Cell preparations typically contained >95% lymphocytes.
Cytotoxicity assay. Cytotoxic activity of the bacterial cul-
ture supernatants was determined by a modification of a
method described previously (16). Briefly, twofold serial
dilutions of unconcentrated culture supernatants or purified
E. coli O111:B4 LPS (1 mg/ml) were made with RPMI-BSA
in microtiter plates (100 RIl/well). Porcine or murine thymo-
cytes (100 ,ul of RPMI-BSA containing 107 viable cells) were
then added to each well, and the plates were incubated at
37°C for 1 h. The plates were centrifuged at 500 x g for 5
min, and the supernatants were removed from the cell
pellets. The cells were resuspended in RPMI-BSA (120
,l/well) containing 0.83 mg of a tetrazolium dye (MTT;
Sigma) per ml. Plates were reincubated at 37°C for 3 h,
followed by centrifugation and removal of the supernatants.
Acid isopropanol (100 IlI/well) was added, and the plates
were vibrated on a microtiter plate shaker to dissolve the dye
precipitate within the cells. The OD570 of each well was
measured in a microtiter plate reader (Dynatech Laborato-
ries Inc., Alexandria, Va.). The percent toxicity was deter-
mined as: [1 - (OD of toxin-treated cells/OD of untreated
control cells)] x 100. Fifty percent toxicity end-point titers
were defined as the reciprocal of the highest toxin dilution
resulting in at least 50% toxicity to the thymocytes.
RESULTS
Pathology. Experimental inoculation of pigs with live A.
pleuropneumoniae serotype 1 and 7 reference strains in-
duced lesions typical of acute pleuropneumonia, including
acute necrohemorrhagic pneumonia with pleuritis and se-
vere suppurative bronchial lymphadenitis. An example of
the thymic lesions induced in pigs by serotype 7 organisms is
shown in Fig. 1B. These lesions were characterized by
moderate multifocal cortical lymphocyte necrosis and drop-
out, as evidenced by lymphocyte karyorrhexis and pykno-
sis with loss of cells in the regions of cortical dendrocytes.
Pigs surviving acute bacterial infection had evidence of
thymic atrophy and a decrease in the normal cortical/
medullary ratio.
Transthoracic inoculation of mice with virulent A. pleuro-
pneumoniae serotypes 1 and 7 induced lesions, including
interstitial pneumonia, purulent pleuritis and lymphadenitis,
lymphoid necrosis of splenic nodules and periarteriolar
lymphatic sheaths, and diffuse acute thymic cortical lym-
phoid necrosis. The acute thymic lesions could be repro-
duced in mice following transthoracic injection of a 10-fold
concentrate of bacterial culture supernatant (Fig. 1D) or by
transthoracic injection of 0.1 mg of purified E. coli G111:B4
LPS (figure not shown). Less severe pyknotic nuclear
changes were also observed in splenic lymphoid nodules in
mice after injection of concentrated culture supernatants.
Transthoracic injection of 10-fold-concentrated uninoculated
medium had no pathologic effect on lymphoid tissues.
In vivo passive protection. Mice injected with the concen-
trated culture supernatant from serotype 1 organisms prein-
cubated with diluted porcine homologous convalescent se-
rum were passively protected from the development of
TABLE 1. Toxicity of culture supernatants
50%o Cytotoxic end-point
Tested material titer for thymocytesa
Murine Porcine
Serotype 7 culture supernatant 16 32
Serotype 1 culture supernatant 64 32
Serotype 1 (heat inactivated)b 8 NDC
Serotype 1 culture retentated 32 ND
Serotype 1 culture filtrated 0 ND
Serotype 7 culture retentated 8 ND
Serotype 7 culture filtrated 0 ND
E. coli LPS 0 0
a Determined as the reciprocal of the highest toxin dilution causing 50%o
toxicity for 10' porcine or murine thymocytes.
b Thawed aliquot of culture supernatant was warmed at 56°C for 30 min.
c ND, activity not determined.
d A thawed aliquot of culture supernatant was filtered through a membrane
with 100-kDa retention. The filtrate was tested for activity, and the retentate
was reconstituted to the original volume and then tested for activity.
thymic lesions (Fig. 1E). Porcine serum from preimmune
animals had no protective capacity, whereas injection of
convalescent serum alone had no toxic effect on thymic
tissue (figures not shown).
In vitro cytotoxicity. Results from in vitro cytotoxicity
assays and cytotoxic 50% end-point titers of E. coli LPS and
various A. pleuropneumoniae culture supernatant prepara-
tions are summarized in Table 1. Unconcentrated culture
supernatants from serotype 1 and 7 reference strains had a
toxic effect on both porcine and murine thymocytes. Warm-
ing a thawed aliquot of the serotype 1 supernatant at 56°C for
30 min reduced the toxicity for murine thymocytes by
eightfold. Cytotoxic analysis of serotype 1 and 7 culture
supernatants filtered through a membrane with a 100,000-
molecular-weight retention showed the retentates, but not
the filtrates, to have cytotoxic activity for murine thymo-
cytes. Concentrations of purified E. coli LPS capable of
inducing acute thymic lesions in vivo were found to have no
in vitro cytotoxic effect on either porcine or murine thymo-
cytes (Table 1).
Serotype 1 culture supernatant was found to have 50%
cytotoxic end-point titers of 8 and 16 for the respective
murine and porcine splenic T-cell preparations, whereas the
serotype 7 culture supernatant possessed a 50o cytotoxic
end-point titer of 4 for each of the respective splenic T-cell
preparations. Serotype 1 culture supernatant biosyntheti-
cally labeled with 35S-methionine retained cytotoxic activity.
Endotoxin determination. The culture supernatant concen-
trates from serotype 1 and 7 reference strains contained 7.8
X 105 and 4.6 x 105 endotoxic units per ml, respectively, or
approximately 7.8 x 10-3 and 4.6 x 10-3 mg of relative
standard endotoxin per ml.
SDS-PAGE, Western blot, and autoradiographic analyses of
toxin preparations. The protein profiles of the 10-fold con-
centrates from serotype 1 and 7 culture supernatants are
shown in Fig. 2 (lanes B and C). Both culture supernatants
contain a 105-kDa protein (arrows) which is absent from the
uninoculated medium control. Western blot analysis of the
concentrate from serotype 1 toxic culture supernatant blot-
ted with various preimmune, convalescent, and adsorbed
convalescent porcine sera is shown in Fig. 3. Convalescent
sera from pigs infected with either the serotype 1 or 7
reference strain reacted with the 105-kDa protein. This
reactivity was not removed by adsorption with A. pleuro-
pneumoniae whole-cell suspensions of either the homolo-
VOL. 59, 1991
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FIG. 2. SDS-PAGE of A. pleuropneumoniae 10-fold-concen-
trated toxic culture supernatants. Lane A, uninoculated RPMI-BSA
medium control; lane B, serotype 1 culture supernatant; lane C,
serotype 7 culture supernatant. Arrows indicate presence of protein
band absent from medium control. Molecular weight markers (103)
are indicated on the left.
gous or heterologous organisms. Serotype 1 convalescent
serum also recognized additional high-molecular-weight
bands in the homologous cytotoxic culture supernatant
(lanes G and H). Serotype 7 convalescent serum failed to
recognize these additional bands. Preimmune porcine sera
failed to recognize the 105-kDa protein or other high-molec-
ular-weight bands. The autoradiograph of the nonreduced
35S-labeled toxin preparation is shown in Fig. 4. This prep-
aration contained bands at 105, 120, and 210 kDa, as well as
several lower-molecular-weight bands.
DISCUSSION
The purpose of this study was to determine whether
infection by A. pleuropneumoniae and secretion of virulence
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FIG. 3. Immunoblot of A. pleuropneumoniae serotype 1 (S1)
lox toxic culture supernatant with the following porcine sera: Si
preimmune serum (lane A), S1 antiserum (lane B), serotype 7 (S7)
preimmune serum (lane C), S7 antiserum (lane D), S7 antiserum
adsorbed with S7 bacteria (lane E), S7 antiserum adsorbed with S1
bacteria (lane F), S1 antiserum adsorbed with S1 bacteria (lane G),
and S1 antiserum adsorbed with S7 bacteria (lane H).
FIG. 4. Autoradiograph of a nitrocellulose blot from a nonreduc-
ing 7% acrylamide gel containing unconcentrated A. pleuropneu-
moniae serotype 1 culture supernatant. Approximate molecular
weights (103) are marked on the left.
factors might adversely affect an animal's lymphoid tissue
and thus impair its ability to mount an effective immune
response. Such impairment could prevent clearance of the
organism after infection and contribute to the establishment
of chronic disease and the carrier state. Previous results
have shown that various serotypes of this organism produce
toxins that kill alveolar macrophages, monocytes, and neu-
trophils (1, 9, 14). Frey and Nicolet (6) have purified a
105-kDa protein from the serotype 1 reference strain and
have demonstrated that it possesses hemolytic activity.
Recently, a protein of similar molecular weight from the
serotype 1 reference strain has been shown to form pores in
phospholipid membrane bilayers (12).
Our results indicate that live bacterial infection by sero-
type 1 and 7 reference strains can induce thymic lesions in
mice and pigs. Such lesions may contribute to organ atrophy
in pigs surviving live bacterial infection. Similar lesions were
reproduced in mice by transthoracic injection of 10-fold
concentrates of sterile culture supernatants from these ref-
erence strains. Thymic lesions could be prevented by prein-
cubation of the concentrated culture supernatants with ho-
mologous porcine convalescent serum. Convalescent sera
from animals infected with either the serotype 1 or 7 refer-
ence strain reacted in immunoblot analysis with a 105-kDa
protein in the concentrated culture supernatant from the
serotype 1 organism. Adsorption of these sera with A.
pleuropneumoniae whole cells of either reference serotype
failed to remove reactivity to this protein, suggesting that it
is a secreted product.
Unconcentrated culture supernatants from both reference
strains were toxic for porcine and murine thymocytes in an
in vitro dye reduction assay. This toxicity was heat labile
and present in a fraction of the supernatant having a molec-
ular weight of >100,000. These results suggest that a high-
molecular-weight product secreted by A. pleuropneumoniae
has cytotoxic activity for thymocytes. That convalescent
sera neutralized lesions in vivo and reacted to a 105-kDa
protein and several high-molecular-weight bands in immu-
noblot analysis suggests that one or several of these proteins
may have a role in cytotoxic activity. In an effort to identify
the macromolecules present in the high-molecular-weight
fraction with in vitro cytotoxic activity, we biosynthetically
labeled the cytotoxic preparation from A. pleuropneumoniae
serotype 1. This fraction contained molecules of 105, 120,
and 210 kDa. Whether any or all of these molecules are
responsible for the cytotoxic activity is not clear; however,
the 210-kDa protein may represent a dimer of the 105-kDa
protein since a single monoclonal antibody recognizes both
molecules (unpublished observation).
That A. pleuropneumoniae can induce thymic lesions in
INFECT. IMMUN.
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swine is a new finding. The exact pathogenesis of these
lesions, however, is still undetermined. The observation that
purified E. coli endotoxin was capable of inducing thymic
lesions in the mouse model suggests that at least some
endotoxins can induce thymic lesions in this system and that
the endotoxin of A. pleuropneumoniae may also play a
significant role in the production of these in vivo lesions. In
contrast, the heat lability of the in vitro toxic effect on
murine thymocytes and the failure of purified E. coli LPS to
produce a direct cytotoxic effect on either murine or porcine
thymocytes suggest the presence of a proteinaceous toxin. It
is also possible that A. pleuropneumoniae endotoxin may
possess biological or species-specific activity different from
that of E. coli endotoxin. The determination of the exact
pathogenic mechanisms involved may require purification of
the cytotoxic substance(s).
Whether or not the induction of thymic lymphoid necrosis
and possible organ atrophy could lead to a generalized
immunosuppression is yet to be determined. There is recent
evidence, however, that animals removed from conventional
herds via a medicated early weaning program and subse-
quently reared in isolation have larger mean thymic weights
and enhanced growth characteristics when compared with
animals reared in the conventional herd (7). These findings
suggest possible relevance to the presence of thymic organ
atrophy related to the overall health of the animal and its
growth potential.
The observation that A. pleuropneumoniae produces a
toxin that can affect T lymphocytes also suggests that the
organism may induce a localized immunosuppression of
mucosal immune responses due to the destruction of local T-
cell populations. A. pleuropneumoniae is known to cause
severe suppurative and necrotizing lymphadenitis of bron-
chial and mediastinal lymph nodes. Similar lesions have
been observed in porcine tonsillar tissues, and the organism
has been isolated from tonsillar crypts long after initial
infection (2, 13). This destruction of secondary lymphoid
tissues may provide a mechanism for persistence of the
organism at mucosal surfaces and facilitate its spread to
susceptible hosts.
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